Identification of a BAC clone overlapping the t(6p12.3) breakpoint in the cell line ESS-1 derived from an endometrial stromal sarcoma

Cancer Genetics and Cytogenetics

Volumn 147, Issue 1, 2003, Pages 84-86

  Gunawan, Bastian ^a   Schulten, Hans Jürgen ^a   Füzesi, László ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER GENETICS; CELL LINE; CHROMOSOME BAND; CHROMOSOME BREAKAGE; CHROMOSOME G BAND; CHROMOSOME IDENTIFICATION; CHROMOSOME MAP; CHROMOSOME TRANSLOCATION 6; DNA SEQUENCE; ENDOMETRIUM SARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ISOLATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; KARYOTYPE; MOLECULAR PROBE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; YEAST ARTIFICIAL CHROMOSOME;

BACTERIA (MICROORGANISMS);

EID: 0142217425     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00186-9     Document Type: Article

References (16)

1. Fresia A.E., Currie J.L., Farrington J.E., Laxman R., Griffin C.A. Uterine stromal sarcoma cell line. A cytogenetic and electron microscopic study. Cancer Genet Cytogenet. 60:1992;60-66.
2. Laxman R., Currie J.L., Kurman R.J., Dudzinski M., Griffin C.A. Cytogenetic profile of uterine sarcomas. Cancer. 71:1993;1283-1288.
3. Hrynchak M., Horsman D., Salski C., Berean K., Benedet J.L. Complex karyotypic alterations in an endometrial stromal sarcoma. Cancer Genet Cytogenet. 77:1994;45-49.
4. Füzesi L., Gunawan B., Braun S., Karl M.C. Endometrial stromal sarcoma with clonal chromosomal aberrations and mixed phenotype. Cancer Genet Cytogenet. 84:1995;85-88.
5. Pauwels P., Dal Cin P., van de Moosdijk C.N.F., Vrints L., Sciot R., van den Berghe H. Cytogenetics revealing the diagnosis in a metastatic endometrial stromal sarcoma. Histopathology. 29:1996;84-87.
6. Iliszko M., Mandahl N., Mrozek K., Denis A., Pandis N., Babinska M., Nedoszytko B., Debniak J., Emerich J., Hrabowska M., Bloomfield C.D., Limon J. Cytogenetics of uterine sarcomas: presentation of eight new cases and review of the literature. Gynecol Oncol. 71:1998;172-176.
7. Gil-Benso R., Lopez-Ginés C., Navarro S., Carda C., Llombart-Bosch A. Endometrial stromal sarcomas: Immunohistochemical, electron microscopical and cytogenetic findings in two cases. Virchows Arch. 434:1999;307-314.
8. Sonobe H., Iwata J., Furihata M., Ohtsuki Y., Taguchi T., Shimizu K. Endometrial stromal sarcoma with clonal complex chromosome abnormalities. Report of a case and review of the literature. Cancer Genet Cytogenet. 112:1999;34-37.
9. Sreekantaiah C., Li F.P., Weidner N., Sandberg A.A. An endometrial stromal sarcoma with clonal cytogenetic abnormalities. Cancer Genet Cytogenet. 55:1991;163-166.
10. Dal Cin P., Aly M.S., De Wever I., Moerman P., Van Den Berghe H. Endometrial stromal sarcoma t(7;17)(p15-21;q12-21) is a nonrandom chromosome change. Cancer Genet Cytogenet. 63:1992;43-46.
11. Hennig Y., Caselitz J., Bartnitzke S., Bullerdiek J. A third case of a low-grade endometrial stromal sarcoma with a t(7;17)(p14 approximately 21;q11.2 approximately 21). Cancer Genet Cytogenet. 98:1997;84-86.
12. Koontz J.I., Soreng A.L., Nucci M., Kuo F.C., Pauwels P., van den Berghe H., Dal Cin P., Fletcher J.A., Sklar J. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci USA. 98:2001;6348-6353.
13. Gunawan B., Braun S., Cortés M.J., Bergmann F., Karl C., Füzesi L. Characterization of a newly established endometrial stromal sarcoma cell line. Int J Cancer. 77:1998;424-428.
14. Albertsen H.M., Abderrahim H., Cann H.M., Dausset J., Le Paslier D., Cohen D. Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. Proc Natl Acad Sci USA. 87:1990;4256-4260.
15. Kazmierczak B., Dal Cin P., Wanschura S., Bormann L., Fusco A., van den Berghe H., Bullerdiek J. HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes Chromosomes Cancer. 23:1998;279-285.
16. Tallini G., Vanni R., Manfioletti G., Kazmierczak B., Faa G., Pauwels P., Bullerdiek J., Giancotti V., Van den Berghe H., Dal Cin P. HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Invest. 80:2000;359-369.